Product Overview – Treatment for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV)

Product Overview – Treatment for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV)

FeLV and FIV Can Now Be Treated with LTCI

Veterinarians and cat owners have anxiously awaited development of a viable treatment for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) for decades. These widespread, incurable viruses—like HIV/AIDS in humans—suppress the immune system and increase the risk of other infections resulting from pathogens (like fungi, which cause ringworm) and bacteria (such as those causing stomatitis and upper respiratory disease). They are the most common causes of cancer in cats.

Now the time has come. A message of hope repudiates the sad, commonly heard refrain of “There is nothing to be done for a cat with FeLV or FIV.”

LTCI (Lymphocyte T-Cell Immunomodulator) is the first—and only—USDA-approved treatment aid for cats infected with FeLV and FIV, and the associated symptoms of lymphopenia, opportunistic infection, anemia, granulocytopenia, and thrombocytopenia.

Because LTCI is new to the market, it will take time for its scientific information to reach veterinarians and animal health organizations. Fortunately, veterinarians and pet owners alike have been very active in sharing the news that FeLV and FIV are no longer death sentences for their cats.

How Does LTCI Work?

LTCI is a naturally-occurring, immune-modulating protein that helps restore a cat’s ability to fight infection. It eliminates impaired CD4 lymphocytes (infection-fighting, specialized white blood cells) and allows new, normal CD4s to produce the cytokines involved in increasing CD8 populations (the “killer” cells that go to infection sites, gobble up bacteria, find and destroy viruses in the body, and knock out cancer cells).

The result is normalization of blood parameters and resolution of opportunistic infections.

LTCI may not be a cure for FeLV or FIV, but when effective, it aids in the treatment of these deadly diseases by restoring (modulating) your cat’s normal immune system.

Safety First

Clients depend on safe products for their pets’ well-being. Veterinarians demand safe products for treating ill patients. LTCI has completed formal safety testing. The homology of LTCI among mammalian species, as well as the absence of any observed adverse events in several animal species, suggests that LTCI has a very low toxicity profile.

PLEASE NOTE: LTCI is restricted to use by or under the supervision of a veterinarian. Veterinarians may order by calling (800) 483-2104 ext. 87 or setting up an online account. Cat owners should contact their veterinarian about ordering or locate a vet already using LTCI.